Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

NAActive, not recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 6, 2016

Primary Completion Date

April 12, 2021

Study Completion Date

December 31, 2027

Conditions
Aortic Aneurysm, ThoracicAorta; Lesion
Interventions
DEVICE

GORE® TAG® Thoracic Branch Endoprosthesis

Endovascular repair with the TBE Device

Trial Locations (35)

14203

Research Foundation SUNY Buffalo, Buffalo

15232

University of Pittsburgh Medical Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

20010

MedStar Health Research Institute, Washington D.C.

21201

University or Maryland Baltimore, Baltimore

23507

Sentara Medical Group, Norfolk

27710

Duke University Medical Center, Durham

28203

Carolinas HealthCare Systems, Charlotte

30322

Emory University, Atlanta

32610

University of Florida - Gainesville, Gainesville

33606

Univeristy of South Florida, Tampa

37232

Vanderbilt University Medical Center, Nashville

38120

Cardiovascular Surgery Clinic, Memphis

40202

University of Louisville Jewish Hospital, Louisville

44195

Cleveland Clinic, Cleveland

46290

St. Vincent Medical Group, Inc., Indianapolis

48109

University of Michigan, Ann Arbor

53792

University of Wisconsin System, Madison

55905

Mayo Clinic Rochester, Rochester

60611

Northwestern University, Chicago

63110

Washington University School of Medicine, St Louis

75093

Heart Hospital at Baylor Plano, Plano

77030

Baylor College of Medicine - Houston, Houston

Houston Methodist Hospital, Houston

Memorial Hermann, Houston

78756

Cardiothoracic and Vascular Surgeons, Austin

90033

Keck Medical Center of USC, Los Angeles

90048

Cedar-Sinai Medical Center, Los Angeles

97239

Oregon Health & Science University, Portland

98195

University of Washington, Seattle

94305-5407

Leland Stanford Junior University, Stanford

06106

Hartford Hospital, Hartford

02114

Massachusetts General Hospital, Boston

03766

Dartmouth-Hitchcock Medical Center, Lebanon

08103

Cooper University Hospital, Camden

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT02777593 - Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 | Biotech Hunter | Biotech Hunter